Moderna: BofA Global Research raises price objective to $220 from $200
MRNA•BofA Global Research raised its price objective for Moderna to $220 from $200.
Related News
Freeport bets on chemical solution to reach copper leaching target
FCX•
AMC Entertainment Holdings, Inc.: B. Riley raises target price to $3.25 from $2.50
AMC•
The GEO Group completes redemption of all senior secured notes due 2029
GEO•
EyePoint announces strategic prioritization
EYPT•
PENN Entertainment target cut to $18 from $20 by Morgan Stanley
PENN•